Fairvalue-Calculator Fairvalue-Calculator
EN DE

EZZ Life Science Holdings (EZZ) Fair Value & Analysis

Healthcare · AU · Market cap A$26.3M

PriceA$0.4450
Fair ValueA$3.15
Upside+607.9%
Quality92/100
Evidence: Low Range A$2.36 – A$7.56

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

EZZ Life Science Holdings (EZZ) currently trades at A$0.4450, while our model-based Fair Value estimate is A$3.15 — implying the stock looks roughly 607.9% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is EZZ Life Science Holdings (EZZ) undervalued?
As of Jun 25, 2026, our model estimates a fair value of A$3.15 versus a price of A$0.4450 — about +608% (undervalued). Model-based estimate, not financial advice.
What is the fair value of EZZ?
Our 21-model fair value for EZZ Life Science Holdings is A$3.15 (as of Jun 25, 2026), built from audited fundamentals. The current price is A$0.4450.
What is the quality score of EZZ?
EZZ Life Science Holdings has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.